http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103709220-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-073 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7072 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H1-00 |
| filingDate | 2014-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103709220-B |
| titleOfInvention | 3-methyluridine and 4-methylcytidine nucleoside compound, synthetic method and pharmaceutical use thereof |
| abstract | The invention discloses 3-methyluridine and 4-methylcytidine nucleoside compound, synthetic method and pharmaceutical use thereof, belong to medicinal chemistry art.This compounds has following general structure:n , this compounds is modified sugared ring and base simultaneously, and add the activity of compound and reduce toxicity, the exploitation for this type of medicine provides good application prospect, can be applied to the preparation of Anti-HBV drugs.Synthetic method is simple, provides condition for synthesizing this compounds in a large number. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3939984-A4 |
| priorityDate | 2014-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 192.